Abstracts

 

2008 Abstract Submission/Revision (CLOSED)

    No Late Abstracts Accepted

 

Abstract Submission Instructions

Abstract Topics & Keywords

 


 

Submission Rules & Guidelines


All authors will be asked to approve the following statement when submitting an abstract: “I have read, understand and agree to the rules and guidelines.” Your abstract will not be programmed if this box has not been checked.

 

  1. An individual may be first author (i.e., presenting author) of only one abstract. The first author's name must be the first author name to appear on the abstract. There is no limit to the number of times an individual may appear as co-author on abstracts.
     

  2. Abstracts must be submitted with the intention that they will be presented if selected. First authors are expected to attend the meeting and make the platform or poster presentation. First authors should not submit abstracts if they do not plan to attend the meeting.
     

  3. With regard to research using human subjects, ASHG endorses the protections embodied in the Basic Principles of the Declaration of Helsinki and their expansion in the regulations governing research supported by the U.S. Government (45 CFR Part 46; 56 FR 28003). ASHG does not endorse and will not publish the results of research that was not conducted in accordance with these Principles. Investigations involving animals reported in abstracts must have been conducted in conformance with approved principles of the care and use of animals in research.
     

  4. To ensure the CME activity meets the ACCME guidelines, first authors must disclose any and all relationships with a commercial interest if the relationship is financial and occurred with the past 12 months and if the individual has the opportunity to affect or may be perceived to affect the content of CME about the products or services of that commercial interest.
     

  5. With regard to research where a gene is identified, the author must present the gene name at the meeting or the abstract will be withdrawn. Authors who do not name the gene at the meeting will be subject to sanctions as determined by the Program Committee.
     

  6. A complete abstract should include a statement of purpose, methods used, and a summary of results in sufficient detail to support the conclusion. Statements such as "results will be described" should be avoided.
     

  7. All abstracts submitted will be assigned either a platform or poster presentation at the discretion of the ASHG Program Committee. The Program Committee reviews all abstracts submitted for presentation at the ASHG Annual Meeting and determines whether an abstract is suitable for platform or poster presentation.
     

  8. Review of Abstracts. All abstracts are reviewed by at least one Program Committee member and two ad hoc reviewers. Names of the reviewers may be obtained by contacting Krista Koziol (kkoziol@ashg.org). The reviewing process is strictly confidential and all reviewers have agreed to the following: "I understand the confidential nature of the abstracts, and I will not discuss their contents with any individual, nor will I make copies of abstracts for my own or others' use. In addition, I will not review any abstracts where conflict of interest may be perceived, i.e., work on which I have authored or co-authored or work completed in laboratories where I work. After completing my reviews, I will return all copies of the abstracts to the Administrative Office of The American Society of Human Genetics."
     

  9. The Program Committee reserves the right to decline a presentation to any submitted abstracts that lack scientific content or merit, or merely announce the availability of a resource or service.
     

  10. Results or studies that have been published or that will be accepted for publication elsewhere prior to the submission deadline of June 19, 2008, may not be accepted for presentation.

 

Publication of Abstracts

 

Abstracts selected for presentation and publication will be available at the ASHG Annual Meeting website after September 25.
 


 

Guidelines for Preparing Effective Posters

 

Download PDF
 


 

Instructions for Plenary/Platform Abstract Presentations

 

View Instructions

 


 

How to Cite an Abstract


Following is a suggested style for citing 2008 abstracts online: Simpson RS, Barnes P, Disruption of the microRNA pathway [Abstract program number xxxx]. Presented at the annual meeting of The American Society of Human Genetics, Date, Location (e.g., November XX, 2008, Philadelphia, Pennsylvania). Available after September 25, 2008 at the following URL: http://www.ashg.org/2008meeting/abstracts/fulltext/*


*Abstracts from previous ASHG annual meetings are available by clicking on the year of the meeting at Past Meetings Archive. In your abstract citation, use the appropriate URL for the meeting in which an abstract was presented.

 

   
   

The American Society of Human Genetics
9650 Rockville Pike
Bethesda, MD 20814
1-866-HUM-GENE | 301-634-7300
Contact Meeting Management
Privacy Policy